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Background: Long-term monitoring in bipolar affective disorders constitutes an important therapeutic and
preventive method. The present study examines the validity of the Personal Life-Chart App (PLC App), in both
German and in English. This App is based on the National Institute of Mental Health’s Life-Chart Method, the de
facto standard for long-term monitoring in the treatment of bipolar disorders.
Methods: Methods have largely been replicated from 2 previous Life-Chart studies. The participants documented
Life-Charts with the PLC App on a daily basis. Clinicians assessed manic and depressive symptoms in clinical
interviews using the Inventory of Depressive Symptomatology, clinician-rated (IDS-C) and the Young Mania Rating Scale
(YMRS) on a monthly basis on average. Spearman correlations of the total scores of IDS-C and YMRS were calculated
with both the Life-Chart functional impairment rating and mood rating documented with the PLC App. 44 subjects
used the PLC App in German and 10 subjects used the PLC App in English. 118 clinical interviews from the German
sub-sample and 97 from the English sub-sample were analysed separately.
Results: The results in both sub-samples are similar to previous Life-Chart validation studies. Again statistically
significant high correlations were found between the Life-Chart function rating assigned through the PLC App
and well-established observer-rated methods. Again correlations were weaker for the Life-Chart mood rating than
for the Life-Chart function impairment. No relevant correlation was found between the Life-chart mood rating and
YMRS in the German sub-sample.
Conclusion: This study gives further evidence for the validity of the Life-Chart method as a valid tool for the
recognition of both manic and depressive episodes. Documenting Life-Charts with the PLC App (English and
German) does not seem to impair the validity of patient ratings.
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The course of bipolar disorder is often characterised by
a multitude of individual, very diverse symptoms [1]. In
most cases, drug combinations are necessary to cope
with these symptoms [2,3]. Given the very large number
of possible drug combinations, it cannot be expected to
find studies in accordance with the criteria of “Evidence
Based Medicine” for all combinations, however. Therefore,* Correspondence: langosch@odebrecht-stiftung.de
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for clinical decisions.
As with many other chronic illnesses, long-term mon-
itoring in bipolar affective disorders (BD) constitutes an
important therapeutic and preventive method. In the
past, it has been demonstrated repeatedly that tools
supporting self-management through the earlier recog-
nition of a pending bipolar episode and increased drug
compliance have a positive impact on the course of
bipolar affective disorders [4,5]. Thus long-term moni-
toring appears to be a source of crucial empirical infor-
mation as a basis for the optimisation of therapy.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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For the long-term documentation of BD in the form of
self-assessment, several patient diaries have been devel-
oped in which patients judge their state of mood and
the severity of manic and depressive episodes at regular
intervals. One of these diaries is the National Institute
of Mental Health’s Life-Chart Method (NIMH-LCM),
which has become the de facto standard for long-term
monitoring in the treatment of bipolar disorders.
The NIMH-LCM can be used to rate the past (“Retro-
spective Life-Chart”) or the present day by day (“Prospect-
ive Life-Chart”). There are clinician-rated and patient-rated
forms of documenting the Life-Charts. Retrospective
Life-Charts are documented on forms covering several
years by month; Prospective Life-Charts are docu-
mented on forms covering one month, day by day.
Combining this information, the self-rated prospective
Life-Chart was used as a “patient diary”.
The variables documented with the NIMH-LCM in-
clude a bidirectional CGI-type Scale for functional impair-
ment due to manic or depressive symptoms. The user
chooses an interval between −4 to +4, with −4 standing
for the maximum impairment due to depressive symp-
toms and +4 representing maximum impairment due to
manic symptoms. Additionally, the lowest and highest
mood of the day is entered on a bar chart or with values
ranging between 0 and 100, with 0 signifying the lowest,
most depressed mood, 50 indicating a balanced mood and
100 for a euphoric mood. Other entered parameters in-
clude the number of mood changes and the presence of
dysphoric mania. For each administered drug, the brand
name, dose with unit, number, pharmaceutical form, side
effects and compliance are recorded, along with sleep dur-
ation, hospitalizations, menstruation, significant life events
or cumbersome situations and any comorbid symptoms.
The extraordinary importance of the continuous, long-
term monitoring of bipolar affective disorders has already
been established through the use of the Life-Chart Method
(LCM) for a long time now [6-8] The Validation of the
clinician-rated prospective LCM was assessed previously.
Mainly two studies provide evidence for the validity of
Life-Chart ratings. The first study correlated clinician-
rated Life-Charts with scores of the Inventory of Depres-
sive Symptomatology and clinician-rated (IDS-C) and with
scores of the Young Mania Rating Scale (YMRS) [9]. The
second study correlated patient-rated Life-Charts with
scores of the Inventory of Depressive Symptomatology,
clinician-rated (IDS-C) as well as with scores of the Young
Mania Rating Scale (YMRS) [10].
The Personal Life-Chart (PLC) originally named Palm
Life-Chart Method (PLC) [11] is an App based on the
NIMH-LCM [11]. Instead of documenting Life-Charts
on paper, patients enter data into the electronic devicesof their choice. The PLC App can be used with both
mobile devices and personal computers connected to
the PLC Cloud. The PLC App method is available in
several languages.
Current study
This study investigates the validity of Life-Charts docu-
mented with the PLC App in the English and German
language versions. The validity analysis was carried out
by comparing the PLC App with pen and paper forms of
well-established psychometric scales.
The primary objective of this study was to investigate
the supposed correlation between impairment of social
function (“function”) and the score of the psychometric
scales Inventory of Depressive Symptomatology, clinician-
rated (IDS-C) [12,13] and Young Mania Rating Scale
(YMRS) [14], both in the depressed and (hypo-)manic
state. The secondary target was to examine the supposed
correlation between self-rated mood and clinician ratings.
Methods
Study description
The method of the study was copied to a large extent
from the two other published Life-Chart validation stud-
ies [9,10]. The substantial difference to these “template
studies” is that in this study the Life-Charts were not
documented with a PEN AND PAPER (P&P) Life-Chart
form, but rather with an ELECTRONIC Life-Chart form,
through the use of the PLC App. As with the template
studies this study was a prospective, multi-site natural
observation study. The validity analysis was done in the
same way as in previous studies: Total Scores of the
Inventory of Depressive Symptomatology, clinician-rated
(IDS-C) and of the Young Mania Rating (YMRS) were
cross correlated with Life-Chart ratings for functional
impairment and mood.
The total study duration was 18 months for each sub-
sample.
Subjects
This study analyses two sub-samples: 44 German-
speaking and 10 English-speaking subjects. Patient net-
works within the German society for bipolar disorders
facilitated the recruitment of the German sub-sample.
This recruitment focussed on the number of patients.
The recruitment of the English sub-sample was facili-
tated by the overseas internships of a doctoral candidate.
Patients were contacted in outpatient departments, on
ward or at events of the German society for bipolar dis-
orders with an invitation document giving an overview
over the study. Subjects interested in study participation
received detailed information with the informed consent
document.
Figure 1 Screenshot, English version.
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Inclusion criteria for the study (for both sub-samples)
were a) DSM-IV diagnosis of BD I or II, BD not other-
wise specified or schizoaffective disorder of bipolar type
b) use of one of the versions of the PLC App in German
or English respectively c) 18 years old or older and d)
the ability to understand the goal of the study and to
give consent.
Diagnoses were ascertained by the study team testing
for DSM IV Criteria with standardized questions (SKID)
whereby an MD confirmed all diagnoses. Despite broader
diagnostic inclusion criteria, only patients diagnosed with
BD I or II participated in the study.
Subjects were recruited from users of the PLC App.
Nevertheless to ensure sufficient experience in the use
of the PLC App, all participants received a standardized
training in the use of the PLC App. A minimum of two
months of Life-Chart usage was required before Life-
Chart data was used for the study.
If questions or technical problems arose, subjects were
able to report this and received immediate assistance by
phone or by personal communication. Study data was
entered in accordance with data protection regulations.
Procedures
The PLC App
The PLC App – for a more detailed description see [11] -
is an electronic diary for patients with bipolar disorder.
The rating period for the electronic diary is the one-day
rating. Participants documented Life-Charts daily with the
App. During the study, patients were able to record and
edit data for the current and the previous day.
Clinical interviews and psychometric testing
Clinical interviews were used to assess the severity of
manic and depressive symptoms. Psychometric Testing
was done through the use of standardised question-
naires. The Inventory of Depressive Symptomatology,
clinician-rated (IDS-C) [12,13] and the Young Mania
Rating (YMRS) [14] were used to measure depressive
and manic symptoms, respectively. The IDS-C rates de-
pressive symptoms for a period of the previous 7 days.
Some IDS-C items report the average symptom severity
in that period (e.g. weight change). Most IDS-C items
assess the maximum severity during that period. The
YMRS rates manic symptoms within the last 48 hours.
The intervals between clinical interviews were 32 days
on average. If patients were likely to show acute manic
symptoms, they were contacted more frequently in order
to capture the typically fleeting acute manic symptoms.
The minimal interval between clinical interviews was 2days, the maximum 205 days (median 23 days). Staff
performed the clinical interviews personally or by phone
due to the sometimes long distances to the outpatients.
First clinical interviews with outpatients and clinical
interviews with inpatients were always conducted in
person, however. The staff was composed of assigned
clinicians and doctoral candidates who successfully com-
pleted inter-rater reliability training. At the time of the
clinical interviews, raters were blind to the Life-Charts
patients entered into their devices.
Data collection
The subjects of the study provided Life-Chart data in
the form of monthly Life-Chart reports printed from the
PLC Cloud using personal computers.
In the German-speaking sub-sample first generation
mobile devices (Palm OS) were used for Life-Chart
documentation. In the English-speaking sub-sample, a
variety of devices were used: PDAs, Smartphones and
web browsers were all utilised to document Life-Charts
(Figure 1). One patient without internet access sent Life-
Chart data to the PLC Cloud using coded text messages
entered into a mobile phone.
The PLC App was used daily to document Life-Charts.
Except for the browser solution and the one patient who
entered data via text messages, Life-Chart data needed
to be transferred from the PLC App to the PLC Cloud
with a patient initiated synchronization process. The en-
tire data collection process is not part of this study.
The data source of this study was the monthly provided
Life-Chart reports, exclusively. The PLC App enables the
integrated printing of the Life-Chart information docu-
mented day by day into these monthly Life-Chart forms
Table 1 Validation of life-charts documented with the
personal life-chart app – A self-monitoring tool for
bipolar disorder [11]
PLC
German
PLC
English
Denicoff et al.
2000 [9]
Born et al.
2014 [10]
IDS-C vs. function −0.73 −0.72 −0.79 −0.72
vs. mood 0.62 0.60 n.a. n.a.
YMRS vs. function 0.53 0.61 0.66 0.49
vs. mood 0.17 0.39 n.a. n.a.
Correlation coefficients in this study (PLC English and German sub-samples)
compared to previous life-chart validation studies.
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in the prior Life-Chart validation studies.
Using this feature, the subjects of the study provided
Life-Chart data in the form of monthly Life-Chart reports
printed from the PLC Cloud using personal computers.
Data analysis
Thus data analysis was based on the paper versions of
the Life-Charts – as with the template studies [9,10].
The assessed scores of the Inventory of Depressive
Symptomatology, clinician-rated (IDS-C) and the Young
Mania Rating Scale YMRS were correlated with the Life-
Chart functional impairment ratings and mood ratings.
Furthermore the monthly Life-Chart report form closely
resembles the paper Life-Chart forms used in the two
aforementioned Life-Chart validation studies. This allowed
for the use of exactly the same method for data analysis as
with the template studies.
For the investigation of the validity of the PLC, Spearman
Correlations were calculated. For calculation of the cor-
relation between Life-Chart and IDS-C we examined
the maximum depression scores (mood and “function”)
documented on the Life-Chart within the 7-day period
rated by the corresponding IDS-C. And in order to
calculate the correlation between the Life-Chart and
YMRS we used the maximum manic scores (mood and
“function”) documented on the Life-Chart within the 48
hour period rated by the corresponding YMRS.
Life-Chart ratings outside of the assessment periods
of IDS-C and YMRS ratings were not included in the
study. Data was stored anonymously in MS Excel files
and analysed with SPSS. Data access was limited to
study staff, according to privacy protection regulations
in Germany.
Results
Description of the sample
This study combines data from two sub-groups: data
from 118 clinical interviews with 44 German-speaking
subjects and from 97 clinical interviews with 10 English-
speaking subjects plus the Life-Chart data of the subjects.
All participants in the German-speaking sub-sample
were outpatients, 23 of them were male and 21 female;
39 subjects came from Germany, 3 subjects from Austria,
one from Switzerland and one from Croatia. All were
native German speakers. The subject’s average age was
40.6. On average 3 clinical interviews were conducted
per patient.
In the English-speaking sub-sample 4 subjects came
from Canada, 3 from South Africa and 3 from the USA.
6 of these native English speakers were male and 4
female, 8 in outpatient and 2 in inpatient care. At the
beginning of the study, the subject’s average age was 34.
On average, the patients’ onset of symptoms had begun8 years before being correctly diagnosed. An average of
9 clinical interviews were carried out per patient.
Most common symptoms
In the IDS-C the most common symptoms were sleep
onset and mid-nocturnal insomnia, sadness, anxiety,
impaired concentration and psychomotor agitation. In
the YMRS, questions about elevated mood, increased
motor activity, energy, irritability and an increase in the
rate and the amount of speech, obtained the highest
scores.
Correlation of life-chart ratings with IDS-C scores
The Personal Life-Chart rating (PLC) of functional im-
pairment by depressive symptoms highly correlates and
statistically significantly with the IDS-C total score in
the German and in the English-speaking sample (see
Table 1). There is also a statistically significant correl-
ation between IDS-C total scores and lowest mood in
both groups.
Correlation of life-chart ratings with YMRS scores
A high and statistically significant correlation was found
between YMRS total score and Personal Life-Chart
rating (PLC) of functional impairment by manic symp-
toms in both samples. The correlation between YMRS
and the highest Life-Chart mood rating was less prom-
inent and significant only in the English-speaking sub-
sample, but not for the German sub-sample. Severely
incapacitating manic symptoms, corresponding to a
Life-Chart functional impairment rating of +4, were not
recorded in this study.
Discussion
The PLC App is derived from the NIMH-Life-Chart
Method, the de facto standard for the long-term moni-
toring of bipolar patients. The NIMH-Life-Chart Method
has been validated in its observer-rated version [9] as well
as recently in its self-rated version [10]. This validation
study replicates the methods and results of these studies
(“template studies”). The Life-Chart function impairment
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nificantly again with IDS-C total score for depression and
YMRS total score for mania. The new aspect of this study
is only, that an electronic Life-Chart form was used in-
stead of the pen and paper Life-Chart forms used in the
template studies. To our knowledge this is the first valid-
ation study for an electronic Life-Chart.
The aim of the PLC App is to provide a validated self-
rating Life-Chart method which is available to everyone
and thus to complement and in some cases even replace
observer-rated methods.
With the PLC App, the patients themselves document
their depressive and manic symptoms. Therefore, the
PLC App is a self-reporting tool as opposed to observer-
rated scales such as the IDS-C or the YMRS. Previous
studies reported that patients recognised self-monitoring
as useful [15]. The electronic methods seem to perform
better than pen and paper methods (P&P) and patients
favoured electronic diaries over P&P [16]. Additionally
the validity of electronic diaries was found to be similar
to the preceding P&P versions [17].
The results of this study confirm previous findings for
P&P Life-Chart versions, too [9,10]. These template
studies found high correlations between IDS-C and the
Life-Chart function impairment ratings (r = −0.785,
p ≤ 0.01 and r = −.718; p < .001). This is similar to the
correlations found in this study (r = −0.726, ≤ 0.01). As
in the template studies, the correlation for YMRS and
Life-Chart Function impairment rating was slightly lower.
Life-Chart functional impairment rating with the
PLC App predicts the severity of depressive symptoms
diagnosed with IDS-C again very well. The high and
statistically significant correlation between patient-
rated Life-Chart functional impairment due to depres-
sive symptoms and the IDS-C total score (−0.717 in
the English speaking and r = −0.726 in the German
speaking sample) give further evidence for the validity
of the Life-Chart method as a tool for the documenta-
tion of both manic and depressive symptoms. Thus
documenting Life-Charts with the PLC App does not
seem to impair the validity of patient ratings.
With the still high and statistically significant correl-
ation (Spearman correlation of 0.610 in the English-
speaking sample and r = 0.531 in the German- speaking
sample) between patient-rated functional impairment
due to manic symptoms registered with the Personal
Life-Chart and the YMRS scores, Life-Charts again dem-
onstrate their potential for the recognition of manic
symptoms. The slightly lower correlation in the mania
range might be explained by reduced illness awareness
at higher levels of mania for some patients, however.
As with the template studies the correlation between
the IDS-C total score and Personal Life-Chart mood rat-
ing was weaker than for Personal Life-Chart functionalimpairment rating (0.6 versus 0.72). This difference was
even more pronounced for YMRS versus Life-Chart
function and mood ratings, respectively. In the German
sub-sample the correlation coefficient was only 0.388
(Spearman) and in the English sub-sample even lower.
The results in both sub-samples are very similar so that
language does not seem to affect the validity of the
ratings.
Some limitations have to be considered:
1. Severe mania hardly occurred in the patient sample,
thus not a single value of +4 for functional
impairment in the PLC App was obtained.
Therefore, the investigation of the validity for
self-rating of severe mania is not part of this study.
And since insight into the illness is more frequently
impaired while experiencing severe mania, it is
plausible not to expect this validity. This does not
impair the clinical value of Life-Chart methods,
because severe mania is easy to recognise for those
in the patient’s environment and usually leads to
rapid treatment, however. As such, the key is to
recognise lower levels of (hypo)mania.
2. The sample was probably representative regarding
the most common symptoms and the duration of
the symptoms until the correct diagnosis. Other
than this, the sample was probably made up of a
very diverse group of patients with different levels
of insight, compliance, familiarity with devices,
intensities of medical care etc. Each of these factors
might influence the validity of the ratings. This
reduces the likelihood of obtaining a statistically
significant result, however. So obtaining a statistically
significant result despite the heterogeneous group
is actually evidence for the strength of effect.
Nevertheless larger studies are needed in order to
identify crucial factors for the validity of the self-ratings
of individual patients.
3. Participants were already well trained in the use of
this Life-Chart method when entering the study.
Patients who are not familiar with Life-Chart forms
(paper or electronic) might not be able to document
valid Life-Charts.
4. The sample size in the English speaking sample was
too small (n = 10) and Life-Chart documentation
methods varied too much as to warrant generalizable
results. However, as results in both sub-samples are
very similar, there is no indication that language,
duration or method of Life-Chart documentation
affects the validity of the ratings. Nevertheless larger
samples are required for validation and even larger
ones to allow for a stratified analysis.
5. Feasibility suffered from the technical challenges of
the first generation of Apps [18]. With the text
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arose, but the non-intuitive syntax took time for
some of the patients to get used to, however. A
certain amount of technical knowledge on the
patient’s side was therefore a prerequisite. Only a
few years later, cloud technology and smartphones
have become both more sophisticated and more
feasible and users have become accustomed to both
(Figure 2).
6. YMRS and IDS-C have not been validated for use in
phone calls. However, clinical interviews by telephone
reflect every day clinical practice and have been used
in other studies. If they were to produce reduced
measurement accuracy with IDS-C and YMRS, this
would result in impaired correlations. So, again,
finding high correlations despite this potential
source of noise is an argument for the validity of
the findings.
Conclusion
This study provides further evidence for the validity of
the Life-Chart method as a tool for the recognition of
both manic and depressive episodes. Documenting Life-
Charts with the PLC App does not seem to impair the
validity of patient ratings, in this group of well-trained
patients.Figure 2 Screenshot, German version, next generation.Thus the use of the PLC App on a daily basis can
allow for continuous monitoring – also between clinical
interviews – which might not be feasible with observer-
rated scales already for financial reasons. With daily rat-
ing, detailed fluctuations can be illustrated, cyclical
courses in terms of Rapid Cycling or Ultra Rapid Cycling
can be recognised more easily and patients are more
likely to remember their symptoms [11]. Compared to
the pen and paper Life-Chart forms, electronic Life-
Chart forms offer the advantage of less missing data; the
automation of labour-intensive steps such as the con-
tinuous graphical analysis of the data saves resources;
and both patients as well as clinicians profit from the
immediate tabulation of the data [4,19].
Following the results of our and previous studies, the
visual analogue scale mood rating is a) inferior to the
bidirectional CGI-type functional impairment rating of
the Life-Chart Method and b) a visual analogue scale
mood rating might not be suitable for rating mania.
Electronic Life-Charts provided by the PLC-App can
enable patients to validly assess the severity of depressive
and manic episodes with functional impairment as well
as with pen and paper Life-Charts. As a self-reporting
tool this electronic diary can cost-effectively comple-
ment observer-rated methods such as the IDS-C or
YMRS.
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